Carlsmed (CARL) Receivables (2024 - 2026)

Carlsmed (CARL) has 3 years of Receivables data on file, last reported at $12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $12.3 million (changed N/A YoY), and the FY2025 full-year result was $11.4 million, up 67.93% from the prior year.
• Receivables for Q1 2026 stood at $12.3 million, up from $11.4 million in the prior quarter.
• Across five years, Receivables topped out at $12.3 million in Q1 2026 and bottomed at $6.8 million in Q4 2024.
• The 3-year median for Receivables is $11.3 million (2025), against an average of $10.3 million.
• Peak annual rise in Receivables reached 67.93% in 2025, while the deepest fall reached 67.93% in 2025.
• A 3-year view of Receivables shows it stood at $6.8 million in 2024, then jumped by 67.93% to $11.4 million in 2025, then rose by 7.97% to $12.3 million in 2026.
• The last three Receivables figures came in at $12.3 million (Q1 2026), $11.4 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.

Peer Comparison